CV Issue 2 2018

6 CORPORATE VISION / Issue 2 2018 , Proton Partners International Ltd is an award-winning healthcare company in the vanguard of advancing high energy proton beam therapy in the UK. The company was formed in 2015 by UK based and international cancer and healthcare specialists. We speak toMikeMoran as we look to find out more about the achievements of the company and his own success. Transforming Cancer Care Recognised as the world’s largest developer of high energy proton beam therapy centres, Proton Partners International is set to build at least five centres across the UK within the next four years. Currently, the company is building oncology centres in Newport, Northumberland, Reading and Liverpool, with an additional site under consideration in London. The company has also made an investment in the UAE to acquire an oncology business, with a view to build a proton therapy centre alongside the existing clinic. Proton Partners International’s oncology centres will be known as the Rutherford Cancer Centres, which reflects the renowned scientist Ernest Rutherford’s contribution in identifying and naming the proton in 1911. At each centre, Proton Partners International aims to treat up to 500 patients annually and, in addition to proton beam therapy, will offer imaging, chemotherapy, radiotherapy, immunotherapy and a range of supportive care services including survivorship and recovery. Treatment will be available to medically-insured private patients, self-paying patients and patients referred by the NHS. The centre in Newport, known as the Rutherford Cancer Centre South Wales, has recently opened for conventional cancer treatments and the high energy proton beam therapy machine, the IBA Proteus®ONE, is undergoing installation and will be patient ready in February 2018. There is a pressing need to make specialised cancer care more accessible worldwide, and high energy proton beam therapy plays an important role in that. The vision of Proton Partners International is to create a better future for cancer patients. The company will achieve this by growing its network of cancer centres, accepting nothing less than excellence and, by developing a patient centred service. In 2010, Mike was awarded an MBE for services to the business community in Hereford and Worcestershire, something he is extremely proud of. Mike starts off by walking us through his career milestones, touching base on his education and his first job role, before explaining how his career has progressed to the level of being selected in the Corporate Excellence Awards 2017 as the 2017 CEO of the Year in the United Kingdom. “Firstly, I was born, raised and schooled in Liverpool and educated in the Army. I enjoyed a military career spanning 20 years as both a soldier and a commissioned officer. Having served all over the world, I retired in 2001 to scratch my business itch which, looking back, was a bold move but one that has paid dividends. “Being very thankful, I have been fortunate to work with some incredible people, including business mentors, investors, bankers, accountants, colleagues and friends. I have always thrived in an environment where I start with a blank sheet of paper; I enjoy setting out the vision and then building a team to deliver it. Clearly, leading Proton Partners International is a highlight in my career to date. I look forward to working further with the incredibly talented team that we have to grow and develop the business further. “In summary, I have over 30 years of experience in strategic leadership, planning and programme delivery in the defence and healthcare sector both in the UK and abroad. Overall, I have significant experience siting on international boards, and I have held several positions as Managing Director and Chief 1712CV19 Executive Officer. Also, I have held various executive positions in defence and healthcare companies, and I am the Former Chairman of the Chamber of Commerce & Learning & Skills Council in Hereford and Worcestershire.” Describing the origins of Proton Partners International, Mike explains his responsibilities as CEO and tells us more about his leadership style which has contributed to his own success, as well as that of his staff. “Basically, the company was formed to respond to the growing global demand for high energy proton beam therapy. The founders had a very clear vision to build a network of cancer centres in the UK and in international markets. We set out to raise £100m in equity and debt to build out the first three proton beam therapy centres. Early equity investors included Woodford Funds and the Wales Life Sciences Investment Fund. The debt provision (£35m) was put in place by Shawbrook Bank which, at the time, was the largest debt provision in the Bank’s history. “With funding in place, we set out to recruit a Board of renowned specialists in healthcare, life sciences and the equity markets. At the same time, I started to